Navigating the Build vs. Buy Debate for Member Engagement Solutions

The evolving landscape of healthcare demands that health plans continuously refine their engagement strategies, making this decision more critical than ever. Plan leaders must consider key factors, including cost, speed, scalability, and effectiveness, to guide them toward the most impactful approach. The post Navigating the Build vs. Buy Debate for Member Engagement Solutions appeared first…

Read More

Q&A: How can providers address challenges in the patient collections process?

Improved automation and data-driven solutions are optimizing the patient collections process, even as providers face rising costs, shrinking reimbursements, looming changes to credit reporting, and an ongoing push toward greater efficiency. How do current solutions stack up against these challenges? Matt Hanas, Lead Product Manager at Experian Health, shares responses to some of the questions…

Read More

A Primer on Health Equity Research

According to the World Health Organization, “Three distinguishing features, when combined, turn mere variations or differences in health into a social inequity in health. They are systematic, socially produced (and therefore modifiable) and unfair. That is how an ISPOR Special Interest Group Report by Griffiths et al. (2025) begins. The health equity primer provides and…

Read More

Denali’s Data in Rare Enzyme Deficiency Keep It on Pace to Seek Speedy FDA Approval

Currently available therapies for Hunter syndrome don’t cross the blood-brain barrier to address cognitive symptoms of the inherited enzyme deficiency. Denali Therapeutics’ technology gets its drug across the protective membrane, and the biotech plans to seek accelerated FDA approval in this rare disease. The post Denali’s Data in Rare Enzyme Deficiency Keep It on Pace…

Read More